257 related articles for article (PubMed ID: 19383306)
21. Cell differentiation lineage in the prostate.
Wang Y; Hayward S; Cao M; Thayer K; Cunha G
Differentiation; 2001 Oct; 68(4-5):270-9. PubMed ID: 11776479
[TBL] [Abstract][Full Text] [Related]
22. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
Reis-Filho JS; Steele D; Di Palma S; Jones RL; Savage K; James M; Milanezi F; Schmitt FC; Ashworth A
Mod Pathol; 2006 Feb; 19(2):307-19. PubMed ID: 16424897
[TBL] [Abstract][Full Text] [Related]
23. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ.
Boecker W; Moll R; Dervan P; Buerger H; Poremba C; Diallo RI; Herbst H; Schmidt A; Lerch MM; Buchwalow IB
J Pathol; 2002 Dec; 198(4):458-67. PubMed ID: 12434415
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
25. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?
Korsching E; Packeisen J; Liedtke C; Hungermann D; Wülfing P; van Diest PJ; Brandt B; Boecker W; Buerger H
J Pathol; 2005 Aug; 206(4):451-7. PubMed ID: 15906273
[TBL] [Abstract][Full Text] [Related]
26. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
27. The cytokeratin profile of medullary carcinoma of the breast.
Tot T
Histopathology; 2000 Aug; 37(2):175-81. PubMed ID: 10931242
[TBL] [Abstract][Full Text] [Related]
28. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
Bryan BB; Schnitt SJ; Collins LC
Mod Pathol; 2006 May; 19(5):617-21. PubMed ID: 16528377
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
30. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
Dabbs DJ; Chivukula M; Carter G; Bhargava R
Mod Pathol; 2006 Nov; 19(11):1506-11. PubMed ID: 16941011
[TBL] [Abstract][Full Text] [Related]
31. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
32. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
33. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948